Page last updated: 2024-09-03
pak 104p and beraprost
pak 104p has been researched along with beraprost in 1 studies
Compound Research Comparison
| Studies (pak 104p) | Trials (pak 104p) | Recent Studies (post-2010) (pak 104p) | Studies (beraprost) | Trials (beraprost) | Recent Studies (post-2010) (beraprost) |
|---|---|---|---|---|---|
| 16 | 0 | 0 | 407 | 61 | 105 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Aikou, T; Akiyama, S; Chen, ZS; Furukawa, T; Kitazono, M; Sumizawa, T | 1 |
Reviews
1 review(s) available for pak 104p and beraprost
| Article | Year |
|---|---|
[Mechanisms for resistance to anticancer agents and the reversal of the resistance].
Topics: Animals; Anion Transport Proteins; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport; Carrier Proteins; Cell Nucleus; Cyclic P-Oxides; Cyclosporine; Cytoplasm; Drug Resistance, Neoplasm; Epoprostenol; Humans; Nicotinic Acids; Protein Binding; Vault Ribonucleoprotein Particles | 1999 |